A critical breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various kinds of tumors, causing https://greatbookmarking.com/story21972566/vhh-fragments-restore-p53-the-new-hope-for-tumor-treatment